ALX Oncology
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boosting the immune system.
63 employees · est. 2015 · South San Francisco, United...
Aston Sci.
Empowering Patients with Innovative Cancer Immunotherapy
8 employees · est. 2018 · Korea South
ALX Oncology is the older company (2015 vs 2018); ALX Oncology is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | ALX Oncology | Aston Sci. |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2018 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Korea South |
| Employees | ||
| Employees | 63 larger | 8 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Series C |
| Total Funding | ||
| Total Funding | $525.20M | $27.00B |
| Funding Rounds | ||
| Funding Rounds | 8 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immuno-Oncology, Cancer Therapy, CD47 Targeting, Clinical-stage Company, Therapeutic Development, Innovation, Biologics, Cancer Research, Hematologic Malignancies, Solid Tumors, Preclinical Stage, Therapeutic Combinations, Fc Domain, Clinical Responses | Clinical-stage Biopharmaceutical, Oncology, Immunology, Cancer Immunotherapy, Therapeutic Cancer Vaccines, Proteostasis Modulators, Geriatrics, DNA, MRNA, Peptide, Drug Development, Pharmaceuticals, Innovation |
| Website | ||
| Website | alxoncology.com | astonsci.com |
About ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company established in 2015. The company's primary focus is on developing therapies that target the CD47 checkpoint pathway in the immune system to combat cancer. Their lead product candidate, evorpacept (ALX148), is a next-generation...
About Aston Sci.
Aston Sci. is a clinical-stage biopharmaceutical company founded in 2018, headquartered in Korea South. The company's slogan, "Empowering Patients with Innovative Cancer Immunotherapy," aligns with its focus on developing innovative medicines in oncology, immunology, and geriatrics. This includes th...
We will tell you when either one moves
BounceWatch watches ALX Oncology and Aston Sci. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ALX Oncology and Aston Sci. — by email.
Frequently Asked Questions
Compare ALX Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ALX Oncology on 9 Jun 2026, and Aston Sci. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.